跳到正文
原文
Regulatory Affairs Professionals Society· @RAPSorg · X·· 2026-10-15AI 评分35
AI 导读

利益相关方敦促FDA在监管可能有助于治疗重度抑郁症和创伤后应激障碍等疾病的致幻药物时保持灵活。 https://hubs.la/Q04BgczL0

正文

Stakeholders are urging FDA to be flexible in how it regulates psychedelic drugs that may help treat conditions such as major depressive disorder and post-traumatic stress disorder.

https://hubs.la/Q04BgczL0

来源:Regulatory Affairs Professionals Society · x.com